<< Back To Home

Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): A cluster-randomized trial

Friday, 15th of March 2019 Print

Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): A cluster-randomized trial

Repurposing of ivermectin, best known for onchocerciasis reduction, to combat malaria

From The Lancet

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32321-3/fulltext?dgcid=raven_jbs_etoc_email

24760492